UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.59B |
| 2 |
AGN
Allergan plc
AGN
|
+$763M |
| 3 |
Boeing
BA
|
+$639M |
| 4 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$542M |
| 5 |
Apple
AAPL
|
+$402M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$377M |
| 2 |
Ecolab
ECL
|
+$332M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$315M |
| 4 |
iShares US Treasury Bond ETF
GOVT
|
+$306M |
| 5 |
CELG
Celgene Corp
CELG
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.74% |
| 2 | Financials | 7.41% |
| 3 | Healthcare | 6.49% |
| 4 | Consumer Discretionary | 5.87% |
| 5 | Industrials | 5.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
iShares US Insurance ETF
IAK
$540M
| $788K | ﹤0.01% |
11,146
+113
| +1% | +$7.69K |
|
3927
Enviri
NVRI
$620M
| $788K | ﹤0.01% |
28,722
+16,851
| +142% | +$412K |
|
3928
Utah Medical Products
UTMD
$225M
| $788K | ﹤0.01% |
8,231
+1,031
| +14% | +$86.8K |
|
|
SHLL.U
3929
DELISTED
Tortoise Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half
SHLL.U
| $788K | ﹤0.01% |
78,801
-2,999
| -4% | -$30.1K |
|
|
AMAG
3930
DELISTED
AMAG Pharmaceuticals
AMAG
| $786K | ﹤0.01% |
78,670
+78,539
| +59,953% | +$847K |
|
3931
Cogent Communications
CCOI
$497M
| $785K | ﹤0.01% |
13,229
-999
| -7% | -$57.3K |
|
|
ARGO
3932
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $784K | ﹤0.01% |
10,594
+5,938
| +128% | +$436K |
|
3933
iShares MSCI BIC ETF
BKF
$78.6M
| $783K | ﹤0.01% |
18,443
-905
| -5% | -$38.1K |
|
|
GLQ
3934
Clough Global Equity Fund
GLQ
$158M
| $783K | ﹤0.01% |
61,186
-1,462
| -2% | -$19K |
|
3935
EXL Service
EXLS
$5.29B
| $781K | ﹤0.01% |
59,015
+54,365
| +1,169% | +$667K |
|
3936
Floor & Decor
FND
$6.68B
| $781K | ﹤0.01% |
18,646
+1,864
| +11% | +$77.9K |
|
3937
1st Source
SRCE
$2.12B
| $781K | ﹤0.01% |
16,832
+4,275
| +34% | +$196K |
|
3938
Fate Therapeutics
FATE
$326M
| $780K | ﹤0.01% |
38,431
+28,877
| +302% | +$520K |
|
3939
CALL
3M
MMM
$94.3B
| $780K | ﹤0.01% |
5,382
-2,392
| -31% | -$368K |
|
|
CHX
3940
DELISTED
ChampionX
CHX
| $779K | ﹤0.01% |
23,223
-6,263
| -21% | -$227K |
|
|
EOD
3941
Allspring Global Dividend Opportunity Fund
EOD
$286M
| $779K | ﹤0.01% |
142,272
-39,625
| -22% | -$213K |
|
|
BBT
3942
Beacon Financial Corp
BBT
$2.66B
| $772K | ﹤0.01% |
24,601
+11,683
| +90% | +$349K |
|
3943
Invesco DB Agriculture Fund
DBA
$1.23B
| $771K | ﹤0.01% |
46,532
-231,041
| -83% | -$3.8M |
|
3944
Shenandoah Telecom
SHEN
$746M
| $771K | ﹤0.01% |
20,028
-3,993
| -17% | -$166K |
|
3945
MGP Ingredients
MGPI
$375M
| $769K | ﹤0.01% |
11,601
+4,680
| +68% | +$330K |
|
3946
First Trust Alerian US NextGen Infrastructure ETF
RBLD
$57.6M
| $769K | ﹤0.01% |
15,409
+942
| +7% | +$46.9K |
|
|
RARX
3947
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $768K | ﹤0.01% |
25,544
+23,716
| +1,297% | +$543K |
|
3948
CALL
Phillips 66
PSX
$81.4B
| $767K | ﹤0.01% |
+8,200
| New | +$736K |
|
|
AAMI
3949
Acadian Asset Management
AAMI
$3.2B
| $767K | ﹤0.01% |
67,199
+23,612
| +54% | +$299K |
|
3950
Radware
RDWR
$1.19B
| $764K | ﹤0.01% |
30,884
-89,945
| -74% | -$2.25M |
|
Similar funds
UBS Group's Q2 2019 Portfolio in Review
As of Q2 2019, UBS Group held 8,581 positions worth $260B, up 7.3% from $242B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group deployed $9.95B of net new capital in Q2 2019, opening 809 new positions and adding to 3,918 existing holdings. Its largest new stake was Dow Inc: 4,472,376 shares worth $221M.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 9.6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $377M trimmed.
- UBS Group's largest Q2 2019 buy was Dow Inc: 4,472,376 shares worth $221M.
- UBS Group added most to UBS Group in Q2 2019, an estimated $1.59B increase.
- UBS Group's biggest Q2 2019 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $377M.
- UBS Group fully exited Bemis in Q2 2019, selling an estimated $102M.
- UBS Group's ten largest holdings make up 14% of its $260B portfolio in Q2 2019.
- UBS Group opened 809 new positions and closed 626 in Q2 2019.
- UBS Group's portfolio value rose 7.3% quarter-over-quarter to $260B.
Based on UBS Group's 13F filing for Q2 2019, filed 14 Aug 2019.